✦ LIBER ✦

Re: Frans Debruyne, Arkadij A. Gres, Dmitrii L. Arustamov. Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia. Eur Urol 2008;54:170–80

✍ Scribed by Tomasz Drewa; Piotr Chlosta

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reply to Tomasz Drewa and Piotr Chlosta'

✍ Frans Debruyne; Arkadij A. Gres; Dmitrii L. Arustamov 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Placebo-Controlled Dose-Ranging Phase 2

✍ Frans Debruyne; Arkadij A. Gres; Dmitrii L. Arustamov 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 561 KB

Placebo-Controlled Dose-Ranging Phase 2

✍ Roehrborn, C.G. 📂 Article 📅 2008 🏛 Elsevier Science ⚖ 54 KB

Editorial Comment on: Placebo-Controlled

✍ Vincenzo Ficarra; Giacomo Novara 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Editorial Comment on: Placebo-Controlled

✍ Mark J. Speakman 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Editorial Comment on: Placebo-Controlled

✍ Patrick J. Bastian 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 66 KB